TEL AVIV SOURASKY MEDICAL CENTER
๐ฎ๐ฑIsrael
- Country
- ๐ฎ๐ฑIsrael
- Ownership
- Private
- Established
- 1961-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.tasmc.org.il
Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis
Phase 2
Terminated
- Conditions
- Ulcerative Colitis
- Interventions
- First Posted Date
- 2020-06-17
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT04434872
- Locations
- ๐ฎ๐ฑ
Department of Gastroentherology, Tel Aviv, Israel
Temporomandibular Disorders Among Patients With Tinnitus
- Conditions
- TinnitusTemporomandibular Disorder
- Interventions
- Other: No intervention
- First Posted Date
- 2020-06-17
- Last Posted Date
- 2020-06-17
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 300
- Registration Number
- NCT04434859
L-arginine and Asymmetric Dimethylarginine (ADMA) and Lifestyle Protocols
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2ObesityArginineAsymmetric Dimethylarginine
- Interventions
- Behavioral: Acute dietary protocols and lifestyle modification
- First Posted Date
- 2020-05-28
- Last Posted Date
- 2020-06-02
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 243
- Registration Number
- NCT04406402
- Locations
- ๐ฎ๐ฑ
Diabetes Unit, E. Wolfson Medical Center, Holon, Israel
Preoperative Nutrition for Crohn's Disease Patients
Phase 3
Not yet recruiting
- Conditions
- MalnutritionCrohn Disease
- Interventions
- Other: High energy / protein diet.Other: Standard nutritionDietary Supplement: Exclusive Enteral Nutrition
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 144
- Registration Number
- NCT04398836
- Locations
- ๐ฎ๐ฑ
Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Evaluation of the Frequency and Severity of Sleep Abnormalities in Patients With Parkinson's Disease
Not Applicable
Recruiting
- Conditions
- Leucine-rich Repeat Kinase 2 (LRRK2) Gene MutationGBA Gene MutationParkinson Disease
- Interventions
- Device: Xtrodes home PSG system
- First Posted Date
- 2020-05-14
- Last Posted Date
- 2023-03-10
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 240
- Registration Number
- NCT04387812
- Locations
- ๐ฎ๐ฑ
Tel Aviv Sourasky Medical Center, Neurology Department, Tel Aviv, Israel
The Effect of Patient's Position After Intra-tympanic Injection
- Conditions
- Sudden Hearing Loss
- Interventions
- Other: Change of posture after Intra Tympanic injection
- First Posted Date
- 2020-05-12
- Last Posted Date
- 2020-05-12
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT04384640
CTFEA Myeloma Study
- Conditions
- Metastatic Bone TumorMyeloma Multiple
- Interventions
- Other: CT-based finite element analysis
- First Posted Date
- 2020-04-28
- Last Posted Date
- 2020-04-28
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT04364724
Fecal Microbial Transplantation for Ileal Pouch Anal Anastomosis Patients
Phase 2
Recruiting
- Conditions
- Ileal Pouch Anal Anastomosis
- Interventions
- Biological: Fecal Microbial Transplantation
- First Posted Date
- 2020-04-07
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT04336319
- Locations
- ๐ฎ๐ฑ
Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Fecal Microbial Transplantation and Vedolizumab Treatment of Crohn's Disease
Not Applicable
- Conditions
- Microbial SubstitutionCrohn Disease
- Interventions
- Other: Fecal microbial transplantationOther: Placebo capsuls
- First Posted Date
- 2020-04-01
- Last Posted Date
- 2020-04-01
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT04328922
- Locations
- ๐ฎ๐ฑ
Department of Gastroentherology, Tel Aviv, Israel
๐ฎ๐ฑDep. of Gastroenterology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
The Effect of Mycobiome Supplementation on Gastrointestinal Symptoms in IBD Patients
Not Applicable
- Conditions
- Ulcerative ColitisInflammatory Bowel DiseasesCrohn Disease
- Interventions
- Dietary Supplement: Mycodigest supplement
- First Posted Date
- 2020-04-01
- Last Posted Date
- 2022-02-01
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT04329481
- Locations
- ๐ฎ๐ฑ
Department of Gastroentherology, Tel Aviv, Israel
ยฉ Copyright 2025. All Rights Reserved by MedPath